The drug company is under no obligation to continue manufacturing the drug after the trial ends, and that's a cold reality.
But what if they are making the exact same drug for another trial? Do they have an ethical obligation to provide it to those that have shown clinical improvement? Can they say no, without looking at the EVIDENCE?
What are your options?
The Right-to-Try Act was designed to give you access to medication, but it does not. Big Pharma makes all the rules. The Federal Drug Administration (FDA) will not help you.
Please join us on this journey. Our hope is to forge a path that others can follow regardless of their disease.